Ex parte HERVE - Page 2




                 Appeal No. 95-0055                                                                                                                     
                 Application No. 07/985,354                                                                                                             


                 1993 (Paper No. 26)).  Claims 45 through 65 are the only                                                                               
                 claims remaining in this application.                                                                                                  
                          According to appellant, the invention relates to a                                                                            
                 biological activator for a septic tank comprising in admixture                                                                         
                 particles of a kaolinite and particles of an essentially                                                                               
                 vitreous material (Brief, pages 3-4).  Claim 45 is                                                                                     
                 illustrative of the subject matter on appeal and a copy of                                                                             
                 claim 45 is reproduced below:                                                                                                          
                 45. A biological activator for a septic tank which activator                                                                           
                 comprises particles of essentially vitreous materials and                                                                              
                 kaolinite.                                                                                                                             

                          The examiner has relied upon the following references as                                                                      
                 evidence of obviousness:                                                                                                               
                 Bavaveas                     4,213,871          Jul. 22, 1980                                                                          
                 Eparco S.A.                  2 357 490          Feb.  3, 1978                                                                          
                 (French Patent)1                                                                                                                       
                          Claims 45 through 65 stand rejected under 35 U.S.C. § 103                                                                     
                 as unpatentable over French Patent 2 357 490 or Bavaveas                                                                               

                          1An English translation of this reference is of record.                                                                       
                 However, as noted by appellant (Brief, page 5, footnote 1),                                                                            
                 French Patent 2 357 490 is the priority document for Bavaveas.                                                                         
                 Neither appellant nor the examiner, in the record before us,                                                                           
                 has pointed to any difference between these references.                                                                                
                 Accordingly, we need only discuss and refer to Bavaveas in our                                                                         
                 decision.                                                                                                                              
                                                                           2                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007